KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business OfficerRead More
We have always been a science driven, customer centric company. This expansion in Geneva helps our clients optimize their complex biomanufacturing processes under accelerated timelines.
This facility expansion, together with our track record in the space, strengthens our commitment to deliver a seamless experience to the European biopharmaceutical community and clients around the globe.
This expansion in Geneva provides our global clients with streamlined capabilities to support mammalian-based therapies.
With a single touchpoint for best-in-class cell line development, process development, and manufacturing, clients experience heightened access to our process and product-based expertise.